George Demetri, Director at Blueprint Medicines Corp (BPMC), sold 12,100 shares at $88.45 ($1.1M) on 2018-02-27, disclosed to the SEC on 2018-03-01.
Open-market sale of $1.1M BPMC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.85 | 2,765 | $243K | 22.8% |
| 2 | $87.85 | 2,765 | $243K | 22.8% |
| 3 | $88.45 | 3,085 | $273K | 25.6% |
| 4 | $88.45 | 3,085 | $273K | 25.6% |
| 5 | $89.48 | 200 | $18K | 1.7% |
| 6 | $90.68 | 200 |
| $18K |
| 1.7% |
| Total | $88.23 avg | 12,100 | $1.1M | 100% |
| Filing → |
| BPMC | SELL | 2021-01-06 | $170K | — | Filing → |
| BPMC | SELL | 2020-09-24 | $145K | — | Filing → |
| BPMC | SELL | 2020-01-14 | $48K | — | Filing → |